Ken Griffin Armata Pharmaceuticals, Inc. Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
Put Options
2 transactions
Others Institutions Holding ARMP
# of Institutions
31Shares Held
771KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$650,1820.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$264,5920.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$250,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$111,7050.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$100,7500.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $90.4M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...